3 weekly) Frequency: Inject 2 mg three times per week (e.g., Monday/Wednesday/Friday) [6]
Although it was approved in 1994, its still a first-choice treatment for diabetes, says Michelle Ponder, MD, an endocrinologist and assistant professor of medicine at Duke University
As early GLP-1 therapies move through their patent lifecycle, pharmaceutical companies face the familiar challenge of maintaining value in the face of eventual generic competition
Finding Your Optimal Dose: Through this process, youll discover the maintenance dose that prevents both weight loss and regain
But the absence of signals in a relatively small, short-duration trial is not the same as a confirmed long-term safety profile
Expansion of GLP-1 drugs It did not take long for other companies to also jump on the GLP-1 bandwagon for the treatment of diabetes